Vaxxas Launches Phase I Trial of H7N9 Vaccine with HD-MAP Technology
Vaxxas announced the start of a multi-center Phase I clinical trial for a vaccine targeting the pre-pandemic avian influenza strain H7N9, using its high-density microarray patch (HD-MAP) technology. Vaxxas has…
EORTC Expands Partnership with Medidata for Next Phase of Cancer Research
Medidata, a Dassault Systèmes brand and leader in clinical trial solutions for the life sciences industry, has announced a four-year extension of its partnership with the European Organisation for Research…
Cellworks Biosimulation Pinpoints NSCLC Patients for Chemo-Immunotherapy Combo
Cellworks Group Inc., a leader in personalized therapy decision support and precision drug development, recently announced the results of a study demonstrating the accuracy of its biosimulation platform in predicting…
New Breast Density Reporting Law Empowers Women; Komen Calls for Affordable Care Access
Susan G. Komen®, the leading breast cancer organization, today applauds the new U.S. Food and Drug Administration (FDA) rule requiring mammography reports to include details about breast density. This federal…
HDS Unveils Script Scan: New Analytics Platform for Pharmacy Performance and Profitability
HDS has launched Script Scan, a new addition to its Spotlight platform. This is the company’s first product specifically designed for pharmacies. Script Scan addresses the current challenges faced by…
Inflammasome Therapeutics Completes Enrollment in Dual Inflammasome Inhibitor Study
Inflammasome Therapeutics, a private company, has finished enrolling participants in a Phase I pharmacokinetics and safety study for its novel drug K9. This brain- and retina-penetrant compound is being evaluated…
CEL-SCI to Present Multikine® Data at ESMO 2024 Congress
CEL-SCI Corporation (NYSE American: CVM) announced that it will present new data from its Phase 3 study of Multikine (Leukocyte Interleukin Injection) at the European Society for Medical Oncology (ESMO)…
Paragon 28 Unveils New Right-Angle Drill for APEX 3D™ Ankle Replacement System
Paragon 28, Inc. (NYSE: FNA) is excited to introduce a new Right-Angle Drill for its APEX 3D™ Total Ankle Replacement System. This innovative tool is designed to enhance tibia preparation…
Cellino Secures $25M Funding from ARPA-H
Cellino Biotech, Inc. announced today that it has been awarded up to $25 million by the Advanced Research Projects Agency for Health (ARPA-H), a division of the U.S. Department of…
Delta-Fly Pharma Begins Phase I/II Study of DFP-10917 with Venetoclax in AML Patients
Following our April 8, 2024, announcement, we’re excited to provide an update on our progress. The U.S. Food and Drug Administration (FDA) approved a Phase I/II clinical trial for DFP-10917…
UpScriptHealth Expands CGM Access for Diabetes Patients in Partnership with Dexcom
UpScriptHealth, a leading direct-to-patient telehealth company offering new distribution channels for pharmaceutical and medical device brands, announced the expansion of its partnership with Dexcom, the global leader in real-time continuous…
Catalyst OrthoScience Hits 10,000 TSA Procedures and Secures $20M Funding
Catalyst OrthoScience Inc., a private medical technology company specializing in shoulder arthroplasty—the fastest growing segment in the orthopedics market—has surpassed 10,000 total shoulder arthroplasty (TSA) procedures. The milestone coincides with…